COVID-19

Revolutionizing Vaccine Storage and Distribution with Innovative Solutions

March 6, 2024 - The global COVID-19 pandemic has highlighted the critical role of vaccines in controlling the spread of infectious diseases. As the demand for vaccines continues to rise, developing innovative solutions for their storage and distribution has become increasingly important. Traditional vaccine storage and distribution methods have faced numerous challenges, including temperature control,...

Read More


More Articles

CDC Recommends Additional COVID-19 Vaccine for Elderly Populations

by Veronica Salib

On Wednesday, February 28, 2024, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend that individuals ages 65 and older get an additional dose of the 2023–2024...

Pediatric Antidepressant Prescription Rates Increased 66%

by Veronica Salib

A recent study published in Pediatrics, the journal of the American Academy of Pediatrics (AAP), revealed a significant increase in antidepressant prescriptions among adolescents, teens, and young...

CVS Report Predicts 2024 Trends in Community Pharmacy

by Veronica Salib

On January 17, 2024, CVS Health published the Rx Report: The Future of Community Pharmacy Open Doors to Healthier Communities, which evaluated a survey in collaboration with the Harris Poll and used it...

Novo Nordisk Launches Vaccine Initiative for Airborne Infections

by Veronica Salib

In an announcement published on December 18, 2023, Novo Nordisk, headquartered in Copenhagen, Denmark, announced its plans to allocate $260 million to research and develop vaccines for airborne...

8 Steps to Negotiating Successful Pharmaceutical Partnerships

by Alivia Kaylor

The pharmaceutical industry is a dynamic and highly regulated sector that offers immense potential for healthcare technology companies seeking collaborative opportunities. By forging strategic partnerships with pharmaceutical companies,...

Pfizer, BioNTech Reveals Data on Combined COVID and Flu Vaccine

by Veronica Salib

Pfizer and its partner, BioNTech, announced positive clinical trial data for an mRNA-based combined vaccine for influenza and COVID-19. The announcement highlights data from a phase 1/2 clinical study...

HHS and Pfizer Reach Paxlovid Agreement to Improve Access

by Veronica Salib

Last week, the United States Department of Health and Human Services (HHS) announced that it had negotiated an agreement with Pfizer Inc. to bolster access to Paxlovid as it enters the commercial...

DEA Extends Telemedicine Prescription of Controlled Medicines

by Veronica Salib

In an announcement on October 6, 2023, the United States Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced that they would extend the COVID-19...

10 Things to Know About the Updated 2023 COVID-19 Vaccines

by Alivia Kaylor

With the onset of the fall season, many Americans are grappling with numerous questions about COVID-19 booster shots, the flu vaccine, and respiratory syncytial virus (RSV) protection. This year's vaccine rollout has encountered...

FDA Authorizes Novavax COVID-19 Vaccines for Circulating Variants

by Veronica Salib

Yesterday, on October 3, 2023, the United States Food and Drug Administration (FDA) announced an emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against the...

Only 46% of US Adults Are Planning to Get the COVID-19 Vaccine Booster

by Veronica Salib

On September 27, 2023, KFF released the results of a survey that assessed how many people plan on getting the newest mRNA COVID-19 vaccine booster. The study's results revealed that only 46% of...

CDC Recommends Updated COVID-19 Boosters This Fall/Winter

by Veronica Salib

Yesterday, the United States Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) met to discuss updated COVID-19 booster recommendations for the...

Vaccinations Needed to Prevent COVID-19 ED Visits, Hospitalization

by Veronica Salib

The coronavirus pandemic has had detrimental impacts on communities across the United States, causing emergency department visits (ED visits), hospitalizations, long-term chronic diseases, financial losses, deaths, and more. The...

How Monoclonal Antibodies Are Shaping the Future of Healthcare

by Alivia Kaylor

Monoclonal antibodies (mAbs), a groundbreaking class of therapeutic agents, have emerged as a transformative tool in modern medicine. With their remarkable precision and versatility, these engineered antibodies offer promising solutions...

GSK Launches New Platform for Tracking Adult Vaccination Rates

by Veronica Salib

As healthcare professionals and public health leaders continue expressing concerns about adult vaccination rates post-pandemic, GSK has launched its new COiMMUNITY Initiative to improve adult vaccine uptake. As part of the initiative, GSK...

Mississippi Study Indicates COVID Vaccines Reduce Myocarditis Risk

by Veronica Salib

At the start of COVID-19 vaccinations, myocarditis rates in Mississippi dropped 14% from pre-vaccination COVID-induced myocarditis rates. The Mississippi-based study was published by a researcher at...

FDA Publishes Draft Guidance for Decentralized Clinical Trials

by Veronica Salib

Yesterday, the FDA published a copy of its draft guidance for decentralized clinical trials, adding to previously issued guidelines. Clinical trial participants may be able to bring trials to their...

US Continues to Increase Its Reliance on Chinese Pharma Supply Chain

by Hayden Schmidt

According to research from the Atlantic Council, pharmaceutical products have become a valuable part of the United States and China’s trading relationship, growing from 0.6% of the total trade to...

Neutralizing Monoclonal Antibodies for COVID-19 Reduces ED Visits

by Veronica Salib

On April 24, 2023, researchers published the results of a cohort study analyzing the effect of neutralizing monoclonal antibodies (nMABs) on patients with COVID-19, noting significantly improved...

Recent Articles